美股市场个股详情

XRAY 登士柏

添加自选

28.290
-0.090-0.32%

收盘价 05/03 16:00 (美东)

28.851
+0.561+1.98%

盘后 17:30 (美东)

58.74亿总市值-64295市盈率TTM

登士柏股票讨论区

登录发表评论

Moomoo AI

02/16 22:24

The company's low growth and lack of profits have led to a stock price drop. A revenue growth acceleration might boost the share price. However, the real benefit for shareholders will be if the company starts making profits. Despite recent gains, the returns over the last three years have been disappointing.

DENTSPLY SIRONA (NASDAQ:XRAY) Shareholders Have Endured a 32% Loss From Investing in the Stock Three Years Ago

Moomoo AI

01/29 21:51

DENTSPLY SIRONA's decreasing capital employment and flat returns are concerning. The stock's decline may reflect investor pessimism about these trends. The analysis does not see the traits of a multi-bagger in this stock.

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Moomoo AI

2023/12/24 22:55

DENTSPLY SIRONA's decision to pay a dividend amidst a reported loss is unsettling. It's not an ideal choice for long-term buy and hold investors.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Goes Ex-Dividend Soon

Moomoo AI

2023/12/19 03:16

Investors predict limited future growth for the company, reflected by its low P/S ratio. The pessimism around its revenue prospect contributes to its undervalued stock.

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Moomoo AI

2023/11/28 19:33

DENTSPLY SIRONA, currently undervalued with steady price trends, could make a solid investment. Despite modest growth projections, aspects like capital structure and management track record could be behind its undervaluation.

Should You Investigate DENTSPLY SIRONA Inc. (NASDAQ:XRAY) At US$31.48?

Moomoo AI

2023/11/10 23:44

The reversal of DENTSPLY SIRONA's stock downward trend might hinge on its profitability. Accelerated revenue growth could yield share price bounce. However, present indications show a 4% annual shareholder loss over five years.

Loss-making DENTSPLY SIRONA (NASDAQ:XRAY) Sheds a Further US$273m, Taking Total Shareholder Losses to 42% Over 3 Years

Moomoo AI

2023/10/20 21:32

There is concern over the falling ROCE and constant capital utilization, pointing towards a likely state of stagnation for the business. Unless there is an improvement in these areas, this stock might not be the best investment option.

Returns On Capital Signal Difficult Times Ahead For DENTSPLY SIRONA (NASDAQ:XRAY)

逍遥投资派

2023/06/22 23:41

$登士柏(XRAY.US)$5年来营收波动中几乎没有变化，营业利润波动中变化也很小，净利润则受资本性资产减值影响，在2018和2022年均大幅亏损，2019和2021年小幅盈利，2020年则小幅亏损。
2023Q1营收增长1%，营业利润下滑43%，净利润继续亏损，目前看不到投资价值。

Moomoo Breakfast US

2022/09/23 20:59

专栏Today's Pre-Market Stock Movers: QCOM, BA, ROKU, AZN and More

Gapping up
In reaction to earnings/guidance:
• $CalAmp(CAMP.US)$ +0.6%
Other news:
• $Cano Health(CANO.US)$ +6.1% ($哈门那(HUM.US)$ in the running to acquire CANO according to WSJ)
• $Corcept医疗(CORT.US)$ +4.5% (extends deal with Optime Care to March 31 2024)
• $LPL Financial(LPLA.US)$ +4.1% (reports monthly activity for August)
• $登士柏(XRAY.US)$ +3% (names new CFO)
• $iPATH 标普500 VIX短期期货ETN(VXX.US)$ +2.9% (tr...

Moomoo Breakfast US

2022/06/02 20:27

专栏Today's pre-market stock movers: CHWY, PATH, SNAP, HPE and more

Gainers:
• $Repare Therapeutics(RPTX.US)$ +26.4% (announces worldwide license and collaboration agreement with Roche for camonsertib)
• $Chewy(CHWY.US)$+19.8% (Chewy stock soars on earnings. Here's what really mattered)
• $UiPath(PATH.US)$ +11.7% ( reported first-quarter revenue growth of 32% year-over-year to $245.1 million)
• $Pure Storage(PSTG.US)$ +10.6% (In reaction to earnings)
• $Credo Technology(CRDO.US)$ +10.2% (In reaction ...

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

美股

综合热度